首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Multiple Sclerosis and Related Disorders
ISSN：2211-0348

Multiple Sclerosis and Related Disorders

MULT SCLER RELAT DIS
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：-
新锐分区：医学3区
年发文量：474
影响因子：2.9
JCR分区：Q2

基本信息

多发性硬化症是一个不断扩大的研究和不断升级的出版物领域。多发性硬化和相关疾病是一个广泛的国际期刊，由来自所有神经科学领域的关键研究人员支持，重点是多发性硬化和中枢神经系统的相关疾病。这本新杂志的主要目的是快速发表该领域的高质量原创研究。重要的次要目标是及时更新和社论重要的科学和临床护理进展，在该领域的争议，并邀请意见文章从当前的思想领袖对热点问题。该杂志的一个部分将集中在教学上，旨在加强社区和学术神经学家参与MS患者护理的实践。为非专业读者撰写的关键文章摘要将作为在线资源提供。由四名主编组成的团队由主要的部门编辑提供支持，他们将委托和评估以下方面的原创文章和评论文章：临床神经病学、神经影像学、神经病理学、神经流行病学、治疗学、遗传学/转录组学、实验模型、神经免疫学、生物标记、神经心理学、神经康复、测量量表、教学、神经伦理学和外行交流。
2211-0348SCIE/Scopus收录
2.9
点击查看最新影响趋势>
2.8
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
CLINICAL NEUROLOGY 临床神经病学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CLINICAL NEUROLOGY
SCIE
Q2
113/286
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CLINICAL NEUROLOGY
SCIE
Q2
96/286
25
474
点击查看年发文量趋势图>
5%---CLINICAL NEUROLOGY-
17.2%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
86.71%18.04%0.78%
CiteScore：5.50
SJR：1.050
SNIP：0.886
学科类别分区排名百分位
大类：Medicine
小类：Neurology (clinical)
Q2
122 / 400
大类：Medicine
小类：Neurology
Q2
63 / 194

期刊高被引文献

Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.01.044
Multiple sclerosis registries in Europe - An updated mapping survey.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.09.032
Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.01.049
Anxiety and depression in patients with multiple sclerosis: The mediating effects of perceived social support.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.09.039
Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.03.017
Worsening of disability caused by relapses in multiple sclerosis: A different approach.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.04.017
Multiple sclerosis and cancer incidence: A Danish nationwide cohort study.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.12.014
Aphasic status epilepticus preceding tumefactive left hemisphere lesion in anti-MOG antibody associated disease.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.10.012
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.01.033
Scientific impact of multiple sclerosis and neuromyelitis optica spectrum disorder research from Southeast Asia: A bibliometric analysis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101862
Two cases of meningitis associated with ocrelizumab therapy.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101866
Saccadic eye movements are able to reduce body sway in mildly-affected people with Multiple Sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.02.005
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101461
To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101908
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/J.MSARD.2019.05.014
Listeria monocytogenes rhombencephalitis in a patient with multiple sclerosis during fingolimod therapy.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.11.025
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101504
The prevalence of multiple sclerosis continues to increase in Kuwait.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.04.033
Risk of relapses during pregnancy among multiple sclerosis patients.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.06.007
Intra-family phenotype variations in familial neuromyelitis optica spectrum disorders.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.02.002
Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.06.009
Validation of 0-10 MS symptom scores in the Australian multiple sclerosis longitudinal study.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101895
TREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohort.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.07.007
Cerebral cortex impairment in neuromyelitis optica spectrum disorder: A case report and literature review.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.04.005
Predictors of vocational status among persons with multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101411
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.07.021
Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101377
Pregnancy outcomes in Portuguese women with multiple sclerosis: The PREGNIMS study.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/J.MSARD.2018.12.033
Illegal cannabis use is common among Danes with multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.05.008
Cognitive speed and white matter integrity in secondary progressive multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.02.021
Cross cultural adaptation and psychometric evaluation of an Arabic version of the modified fatigue impact scale in people with multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101878
Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101507
Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101387
Relative importance of vision and proprioception in maintaining standing balance in people with multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101901
Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101444
Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101479
Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101488
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101494
An uncommon neurological manifestation of chronic lymphocytic leukemia: Longitudinally extensive transverse myelitis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101455
Mitochondrial DNA G15927A and G15928A variations in patients with multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.09.004
Neuromyelitis optica spectrum disorder occurred after interferon alpha therapy in malignant melanoma.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.04.023
Abnormalities and erythroblasts in peripheral blood of multiple sclerosis patients treated with natalizumab.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101382
Profile of Polish patients with primary progressive multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.05.009
Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test).
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2018.12.003
Magnetic resonance imaging markers of disability in Egyptian multiple sclerosis patients.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101417
Unusual cortical involvement in aquaporin-4 antibody-positive patients: An analysis with double inversion recovery and phase-sensitive inversion recovery imaging.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.01.020
Prognostic impact of epilepsy in multiple sclerosis.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101497
Fulminant and fatal onset of pan-aquaporinopathy.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.06.029
Is diet associated with physical capacity and fatigue in persons with multiple sclerosis? -Results from a pilot study.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101921
Assessing life balance of European people with multiple sclerosis: A multicenter clinimetric study within the RIMS network.
来源期刊：Multiple sclerosis and related disordersDOI：10.1016/j.msard.2019.101879

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
CLINICAL NEUROLOGY 临床神经病学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
CLINICAL NEUROLOGY 临床神经病学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
CLINICAL NEUROLOGY 临床神经病学
4区
否
否